Logo
x

Search

Subscribe Now

CT-P59

Celltrion's Regdanvimab (CT-P59) Receives the ANVISA's EUA for the Treatment of COVID-19 in Brazil

Celltrion's Regdanvimab (CT-P59) Receives the ANVISA's EUA for the Treatment of COVID-19 in Brazil

  • August 13, 2021
Celltrion Launch P-III Post-Exposure Prophylaxis Clinical Trial of CT-P59 for COVID-19

Celltrion Launch P-III Post-Exposure Prophylaxis Clinical Trial of CT-P59 for COVID-19

  • October 14, 2020
Celltrion Initiates P-I Study of CT-P59 Against COVID-19 in Korea

Celltrion Initiates P-I Study of CT-P59 Against COVID-19 in Korea

  • August 27, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.